High-Expressed Macrophage Scavenger Receptor 1 Predicts Severity Clinical Outcome in Transplant Patient in Idiopathic Pulmonary Fibrosis Disease

Table 1

Clinical characteristics of cases in this study.

	Pulmonary arterial hypertension secondary to IPF (PAH)	IPF patients with severe fibrosis (lung transplant patients)	value
Clinical data
	15	37
Sex	3 females; 12 males	5 females; 32 males	0.870
Age (yr) ()			0.725
Smoking in history (percent)		32.4% (12/37)	0.683
BMI ()			0.661
Lung function
FEV1 ()
FVC ()
TLC ()		1
TLCO ()
Medication
Prednisolone	100%	100%
Azathioprine	0	0
N-Acetylcysteine	100%	100%

Definitions of abbreviations: PAH = pulmonary arterial hypertension; IPF = idiopathic pulmonary fibrosis; TL_CO = diffusing capacity of carbon monoxide. ^a Significant differences between the groups: p <0.05.